Expression of S100A11 is a Prognostic Factor for Disease-free Survival and Overall Survival in Patients With High-grade Serous Ovarian Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Medical Laboratory Technology,Histology,Pathology and Forensic Medicine
Reference43 articles.
1. Ovarian cancer;Chobanian;Surg Clin North Am,2008
2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
3. New insights into the pathogenesis of serous ovarian cancer and its clinical impact;Levanon;J Clin Oncol,2008
4. Differences in tumor type in low-stage versus high-stage ovarian carcinomas;Köbel;Int J Gynecol Pathol,2010
5. Are all pelvic (nonuterine) serous carcinomas of tubal origin?;Przybycin;Am J Surg Pathol,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12);Biology;2023-06-19
2. Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance;BioMed Research International;2021-03-03
3. Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study;Molecules;2021-01-14
4. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis;Technology in Cancer Research & Treatment;2021-01-01
5. The Serum and Saliva Proteome of Dogs with Diabetes Mellitus;Animals;2020-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3